Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
ASMD Phenotypes

ASMD Phenotypes

Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control

Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control

Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs

Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs

ADA 2021: Solimix Trial Summary

ADA 2021: Solimix Trial Summary

Regulate LDL-C level for those undergoing coronary revascularization (Diabetic Patients)

Regulate LDL-C level for those undergoing coronary revascularization (Diabetic Patients)

Prophylactic Strategies for VTE in Gynecologic Cancer Patients

Prophylactic Strategies for VTE in Gynecologic Cancer Patients

Real-life safety and efficacy of Alirocumab - Odyssey apprise study

Real-life safety and efficacy of Alirocumab - Odyssey apprise study

Safety and efficacy of alirocumab in patients with Hypercholesterolemia and high cardiovascular risk in a real-life setting.

Importance of lipid registries in cardiovascular prevention

Importance of lipid registries in cardiovascular prevention

Optimal use of LLT after ACS

Optimal use of LLT after ACS

The Lixilan-L Study

The Lixilan-L Study

Italian real-world analysis for PCSK9 inhibitors new users

Italian real-world analysis for PCSK9 inhibitors new users

Italian real-world analysis on management and pattern of PCSK9 inhibitor use in the first six months of treatment

NEJM Odyssey outcomes

NEJM Odyssey outcomes